|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0012634,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0439234,
umls-concept:C0449450,
umls-concept:C0871261,
umls-concept:C1332225,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2603343,
umls-concept:C2911692
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1997-9-8
|
|
pubmed:abstractText |
To clarify disease characteristics and optimal treatment for elderly patients with non-Hodgkin's lymphoma (NHL), we performed a randomized trial in 453 patients older than 69 years with aggressive lymphoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BastionYY,
pubmed-author:BlandLL,
pubmed-author:BlayJ YJY,
pubmed-author:BordessouleDD,
pubmed-author:BrièreJJ,
pubmed-author:BricePP,
pubmed-author:CoiffierBB,
pubmed-author:DeconinckEE,
pubmed-author:DivineMM,
pubmed-author:DumontetCC,
pubmed-author:LederlinPP,
pubmed-author:SallesBB,
pubmed-author:SebbagDD,
pubmed-author:TillyHH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2945-53
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9256139-Aged,
pubmed-meshheading:9256139-Aged, 80 and over,
pubmed-meshheading:9256139-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9256139-Blood Cells,
pubmed-meshheading:9256139-Cyclophosphamide,
pubmed-meshheading:9256139-Doxorubicin,
pubmed-meshheading:9256139-Female,
pubmed-meshheading:9256139-Humans,
pubmed-meshheading:9256139-Lymphoma, Non-Hodgkin,
pubmed-meshheading:9256139-Male,
pubmed-meshheading:9256139-Prednisolone,
pubmed-meshheading:9256139-Prednisone,
pubmed-meshheading:9256139-Prospective Studies,
pubmed-meshheading:9256139-Survival Rate,
pubmed-meshheading:9256139-Teniposide
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.
|
|
pubmed:affiliation |
Service d'Hématologie, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
